ArticleAnnals of dermatology2026

Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea.

Narang Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.